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Abstract
Introduction
In 2005, the Centers for Disease Control and Prevention 
funded  five  sites  to  implement  the  Colorectal  Cancer 
Screening Demonstration Program (CRCSDP). An evalu-
ation  is  being  conducted  that  includes  a  multiple  case 
study. Case study results for the start-up period, the time 
between initial funding and screening initiation, provide 
details  about  the  program  models  and  start-up  process 
and reveal important lessons learned.
Methods
The multiple case study includes all five CRCSDP sites, 
each representing a unique case. Data were collected from 
August 2005 through September 2006 from documents, 
observations, and more than 70 interviews with program 
staff and stakeholders.
Results
Sites  differed  by  geographic  service  area,  screening 
modality selected, and service delivery structure. Program 
models were influenced by two factors: preexisting infra-
structure and the need to adapt programs to fit local ser-
vice delivery structures. Several sites modeled program 
components  after  their  National  Breast  and  Cervical 
Cancer Early Detection Program. Medical advisory boards 
convened by all sites provided clinical support for devel-
oping  program  policies  and  quality  assurance  plans. 
Partnerships with comprehensive cancer control programs 
facilitated access to financial and in-kind resources.
Conclusion
The program models developed by the CRCSDP sites 
offer a range of prototypes. Case study results suggest ben-
efits in employing a multidisciplinary staff team, assem-
bling a medical advisory board, collaborating with local 
partners, using preexisting resources, designing programs 
that are easily incorporated into existing service delivery 
systems, and planning for adequate start-up time.
Introduction
Colorectal cancer is the second leading cause of cancer-
related death in the United States (1). Although strong 
scientific evidence suggests that regular colorectal cancer 
screening is effective in helping to reduce incidence and 
mortality from this disease (2), less is known about how 
to effectively implement colorectal cancer screening in a 
population-based setting. In this context, the Centers for 
Disease Control and Prevention (CDC) funded five sites in 
August 2005 to implement the Colorectal Cancer Screening 
Demonstration  Program  (CRCSDP)  for  a  3-year  period 
and  planned  an  evaluation  to  assess  its  feasibility.  The 
five grantee organizations are the Maryland Department 
of Health and Mental Hygiene, the Missouri Department 
of Health and Senior Services, the Nebraska Department 
of Health and Human Services, Stony Brook University 
Medical  Center,  and  Public  Health  –  Seattle  &  King 
County.
Before funding the CRCSDP, CDC used Framework for 
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Program Evaluation in Public Health (3) to develop an 
evaluation  plan  with  three  purposes:  1)  understanding 
program  implementation  (processes);  2)  measuring  pro-
gram effects (outcomes) at the individual client level, and 
3) assessing program efficiencies (costs). CDC adopted a 
goal-based (4), utilization-focused (5) evaluation approach 
and developed evaluation questions, consistent with the 
purposes  above,  for  each  of  eight  CRCSDP  program 
goals,  which  were  defined  on  the  basis  of  the  program 
components.  CDC  selected  three  methods  to  evaluate 
the CRCSDP: 1) a multiple case study, 2) the collection 
and analysis of clients’ screening and diagnostic services 
data, and 3) a costs and cost-effectiveness analysis. CDC 
is collecting and analyzing data for two distinct periods: 
1) program start-up (i.e., the time between initial funding 
and  the  initiation  of  screening  services)  and  2)  screen-
ing implementation. This report summarizes case study 
results for the start-up period, describes the five unique 
program models and the start-up process, and identifies 
important lessons learned.
Methods
The study team conducted a multiple case study to bet-
ter  understand  program  implementation  processes  and 
to describe the experience and context of each CRCSDP 
program. A multiple case study approach was used in part 
because it would allow comparisons between the five sites. 
All five CRCSDP programs were included in the multiple 
case study (6,7), each representing a unique case. Table 1 
presents the eight CRCSDP program goals and offers exam-
ples of evaluation questions addressed by the case study.
Data collection 
The study team collected data from documents, inter-
views,  and  observations  from  August  2005  through 
September  2006.  Key  documents  were  summarized  by 
using  a  structured  guide,  and  other  documents  were 
retained  in  their  entirety.  Documents  included  funding 
proposals to CDC for the first 2 years of the CRCSDP pro-
gram, program policies, patient flowcharts, and minutes 
from an all-site conference call. In February and March 
2006, the team conducted a telephone interview, using a 
semistructured interview guide, with the program director 
for each site; three in-person interviews were also conduct-
ed with CDC program consultants who provided technical 
assistance and other support to the sites.
The  team  made  2-day  visits  to  each  program  site 
during  summer  2006  to  record  observations  and  con-
duct interviews with staff and stakeholders. Ten unique, 
semistructured interview guides were developed for the 
following positions: bureau chief, program director, pro-
gram  coordinator,  quality  assurance  coordinator,  out-
reach coordinator, epidemiologist, medical advisory board 
(MAB)  member,  provider  site  coordinator,  endoscopist, 
and Comprehensive Cancer Control (CCC) coordinator or 
other partner. The team identified these roles on the basis 
of typical staffing patterns among the sites and program 
policies imposed by CDC (e.g., programs must convene an 
MAB). Interview questions were developed on the basis of 
the role of the interviewee, the evaluation questions, and 
information gathered during the earlier interviews with 
program  directors  and  CDC  program  consultants.  The 
team used purposeful sampling to select interviewees who 
were likely to provide the most in-depth information (5); 
relevant stakeholders were identified with assistance from 
program staff. A team of two evaluators conducted most 
interviews,  which  were  audiotaped  and  lasted  approxi-
mately  60  minutes.  The  team  conducted  a  total  of  67 
interviews (30 staff and 37 stakeholders). On the basis of 
informal observations conducted at all sites, descriptive 
field notes were developed.
Analysis 
Data analysis involved an iterative approach whereby 
team members regularly met to discuss impressions, review 
field notes, identify themes, and consider areas of empha-
sis for subsequent interviews (8). The team transcribed 
all  interviews  and  entered  them  along  with  documents 
and document summaries into Atlas.ti (Atlas.ti Scientific 
Software Development GmbH, Berlin, Germany), a soft-
ware  program  for  qualitative  data  analysis.  Categories 
and themes were developed both inductively from the data 
(e.g.,  challenges  in  recruiting  endoscopists)  and  deduc-
tively from the evaluation questions (e.g., description of 
partnership activities).
The team developed and refined a codebook with detailed 
code definitions. A single evaluator was assigned to code 
all interviews for one program site. The team coded 65 
of  the  67  on-site  interviews,  excluding  two  interviews 
because the interviewees were unfamiliar with details of 
their sites’ CRCSDP program. Because of resource limita-
tions, the documents were not coded, nor were the five 
telephone interviews with program directors or the three 
2  Centers for Disease Control and Prevention • www.cdc.gov/pcd/issues/2008/apr/07_0204.htm
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, 
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only 
and does not imply endorsement by any of the groups named above.interviews with program consultants, but these materials 
were used in the analysis.
The team met twice weekly during the coding process to 
discuss issues and review the memos of each team mem-
ber. A second team member coded half of all interviews for 
each site; the two coders discussed discrepancies to make 
final coding decisions. The constant comparative method 
(9)  was  used  to  compare  categories  of  data  at  different 
levels. Inferences from the coded data were made using 
content analysis (10). The team developed typologies (e.g., 
classifying service delivery models) and tables as an addi-
tional way to understand the organizational arrangements 
and  service  delivery  processes  (11).  Finally,  within-case 
analysis (6) was conducted for each of the five programs, 
and case-specific reports were developed.
Credibility 
Each  member  of  the  evaluation  team  engaged  in  all 
aspects of data collection and analysis, an approach that 
contributed to a thorough and holistic understanding of 
each case. Both methodologic and data-source triangula-
tion  were  used  to  verify  findings;  using  more  than  one 
source of evidence is known to strengthen findings (11-14). 
The team maintained a detailed audit trail documenting 
the research methods and process to ensure transparency 
(13). Finally, the process of member checking was used for 
the in-case analysis (12,15); this process engages research 
participants in a review of tentative findings to verify their 
accuracy.
Results
We present results for two distinct areas. The first, pro-
gram models, summarizes characteristics of each CRCSDP 
program model. The second, program processes, presents 
data related to key start-up processes.
Program models 
The  five  sites  differed  in  geographic  service  area: 
two  served  a  city  (Baltimore,  Maryland,  and  St.  Louis, 
Missouri); two served counties (Suffolk County, New York; 
and King, Clallam, and Jefferson counties, Washington); 
and one served a state (Nebraska).
Missouri, Nebraska, and Washington planned to use the 
guaiac-based fecal occult blood test (FOBT) as the primary 
screening test, with colonoscopy being used for diagnosis 
and screening of high-risk people (Table 2). Maryland and 
New  York  planned  to  use  colonoscopy  as  their  primary 
screening test. On the basis of CDC guidelines related to the 
priority population for the program, we found consistency 
between the populations served by the five programs.
The organizational relationships for the programs’ ser-
vice delivery systems varied (Figures 1–5). Nebraska and 
New  York  planned  to  deliver  screening  services  them-
selves.  Maryland,  Missouri,  and  Washington,  however, 
planned to provide program oversight and contract with 
other  agencies  to  deliver  screening  services.  Missouri, 
Nebraska,  and  New  York  planned  centralized  service 
delivery systems, but Maryland and Washington planned 
decentralized systems.
The Missouri Department of Health and Senior Services 
planned to contract with a provider in St. Louis to assess 
client eligibility for screening, deliver FOBT services, track 
and follow up on clients, and provide colonoscopies (Figure 
1).  The  Nebraska  Department  of  Health  and  Human 
Services planned to assess client eligibility for screening 
and deliver FOBT services, but to contract with outside 
providers  for  tracking  and  follow-up,  laboratory,  and 
colonoscopy  services  (Figure  2).  Stony  Brook  University 
Medical Center in New York represents an enclosed system 
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Figure 1. Centralized provider system for the Colorectal Cancer Screening 
Demonstration Program, Missouri. Both the specialty care center and 
cancer center provide endoscopic services. CCC indicates Comprehensive 
Cancer Control; NBCCEDP, National Breast and Cervical Cancer Early 
Detection Program, FOBT, fecal occult blood test.VOLUME 5: NO. 2
APRIL 2008
in which departments within the medical center planned to 
conduct all aspects of service delivery (Figure 3).
Of the sites with decentralized models of service delivery, 
the Maryland Department of Health and Mental Hygiene 
(Figure 4) planned to contract with five hospitals, each 
of which would provide all elements of screening service. 
In Washington, Public Health – Seattle & King County 
planned to contract with 10 primary care centers to assess 
screening eligibility, deliver FOBT services, ensure track-
ing and follow-up, and provide laboratory services (Figure 
5). The plan also called for contracting with 1) another 
agency  to  provide  patient  navigation  services  to  people 
referred for colonoscopy and 2) several endoscopists to con-
duct colonoscopy. In general, staff members in Maryland 
and  Washington  valued  the  decentralized  model  for  its 
community-based orientation but perceived the model as 
more difficult to establish because of the need to support 
multiple sites in integrating and adapting the program 
into their existing service delivery systems.
Two key factors influenced the program design of all five 
programs. First, several sites developed the new CRCSDP, 
or components of it, from existing programs such as the 
National  Breast  and  Cervical  Cancer  Early  Detection 
Program (NBCCEDP). For instance, sites planned to use 
NBCCEDP provider networks to support client in-reach or 
to distribute FOBT kits and were in the process of integrat-
ing other program components with existing NBCCEDP 
components. One staff member noted, “The easy part for 
us was having a screening and tracking system in place 
already  that  we  were  comfortable  with  [NBCCEDP]. 
 . . . We were able to use similarities in our existing sys-
tem and customize those for CRCSDP.” The second factor 
influencing the CRCSDP program models was the need 
for sites to tailor service delivery systems in ways that 
facilitated  their  integration  into  existing  clinical  struc-
tures.  Participants  said  such  integration  was  necessary 
to minimize the burden and disruption for participating 
clinical sites. For decentralized models, the need to “fit” 
the provider context resulted in unique patient flow pat-
terns at multiple provider settings.
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Figure 2. Centralized provider system for the Colorectal Cancer Screening 
Demonstration Program, Nebraska. NBCCEDP indicates National Breast 
and Cervical Cancer Early Detection Program; FOBT, fecal occult blood test; 
CCC, Comprehensive Cancer Control. 
Figure 3. Centralized Provider System for the Colorectal Screening 
Demonstration Program, New York.
Figure 4. Decentralized provider system for the Colorectal Cancer 
Screening Demonstration Program, Maryland. CCC indicates Comprehensive 
Cancer Control.Start-up processes
The start-up process lasted 9 to 11 months and involved 
assembling  a  staff  team,  developing  program  models, 
convening  a  MAB  to  assist  in  developing  policies  and 
procedures,  building  partnerships,  planning  for  client 
recruitment, developing a data management system, and 
identifying resources for the treatment of complications.
Staffing
Each program recruited a team of two or three people, 
usually from existing positions, to assist in developing the 
new program. Teams typically included a program director, 
a program coordinator working on day-to-day activities, and 
a data management specialist. Programs that were able to 
easily access staff with clinical expertise within the grantee 
organization noted the importance of being able to do so. 
Nearly all CRCSDP program directors were also managing 
their state or region’s NBCCEDP, and some were managing 
a  Well–Integrated  Screening  and  Evaluation  for  Women 
Across the Nation (WISEWOMAN) program, another CDC-
funded  screening  program  (16).  Program  directors  had 
extensive program and management experience and pre-
existing partner relationships with cancer prevention and 
control leaders in their state. The team approach helped 
ensure that enough people with varied expertise were avail-
able to attend to the many start-up responsibilities.
Medical advisory board 
An MAB was convened by each program and provided 
essential  clinical  guidance  during  the  start-up  period, 
especially for CRCSDP sites lacking staff with extensive 
medical expertise in colorectal cancer. MAB composition 
varied  by  site  but  largely  reflected  clinical  disciplines 
relevant to colorectal cancer and screening, including pri-
mary care specialists, gastroenterologists, and radiologists 
(Table  3).  One  respondent  suggested  that  the  prescrip-
tion for a well-rounded MAB includes “basically anybody 
involved in any step of the way from screening to diagnosis 
to treatment, a continuum of care, with a heavy emphasis 
on  GI  [gastrointestinal  specialists].”  The  MABs  served 
as a functional work group, providing direction on policy 
development,  program  eligibility  criteria,  patient  flow, 
data collection, and quality assurance. MABs participated 
informally, meeting as a group infrequently but otherwise 
being accessible to program staff by telephone and e-mail.
Partnerships 
Partnerships provided critical resources, both financial 
and  in-kind,  and  played  an  active  role  during  program 
start-up.  Key  partners  included  state  or  regional  CCC 
groups, the American Cancer Society (ACS), community-
based  organizations,  and  universities.  Several  partners 
provided in-kind staff support, and CCC groups contrib-
uted financial resources for a public education campaign 
in one site and database development in two others. CCC 
groups  were  also  valuable  in  negotiating  relationships 
with  MAB  members,  endoscopists,  and  representatives 
of  clinical  provider  sites.  An  ACS  call  center  planned 
to recruit CRCSDP clients for one program, and a local 
university planned to assist with client recruitment and 
evaluation in another.
Client recruitment 
CRCSDP sites planned public education, outreach, and 
in-reach strategies to recruit clients for screening (Table 
4). Several sites adopted CDC’s Screen for Life: National 
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Figure 5. Decentralized provider system for the Colorectal Cancer 
Screening Demonstration Program, Washington. ACS indicates American 
Cancer Society; CIS, Cancer Information System; CCC, Comprehensive 
Cancer Control; FOBT, fecal occult blood test. The Colorectal Cancer Task 
Force is a subcommittee of the statewide CCC that was established to 
address colorectal cancer issues.VOLUME 5: NO. 2
APRIL 2008
Colorectal Cancer Action Campaign or ACS public edu-
cation materials. Staff emphasized the use of culturally 
sensitive  public  education  materials.  Although  public 
education efforts were intended to raise awareness about, 
and create demand for, the new CRCSDP, interviewees 
expressed apprehension about creating too great a demand 
for screening services early in program implementation. 
Staff planned to begin with a slow process of recruitment 
so they could test their systems. Ten Suffolk County com-
munity  health  centers  collaborated  with  the  New  York 
program  during  the  start-up  period  to  develop  a  plan 
for referring clients for screening. Other CRCSDP sites 
focused  on  developing  in-reach  efforts  to  recruit  clients 
from existing screening programs such as the NBCCEDP. 
However, interviewees expressed concerns about recruit-
ing men for the CRCSDP through NBCCEDP, observing 
that  men  generally  are  less  likely  to  access  preventive 
health care services. One stakeholder noted the following: 
“All of the people from the men’s health sector say that 
the only thing men say is that ‘my wife made me do it’ [get 
screened]. All of the doctors say that, too, that men say 
their wives made them come in. But we don’t want to put 
all of that burden on women. Women are used to getting 
screenings and doing preventive care; it’s not part of the 
culture for men.”
Data management systems 
During program start-up, CDC, in collaboration with the 
five CRCSDP sites, developed a set of colorectal clinical 
data elements to collect patient-level demographic, screen-
ing,  and  diagnostic  data  on  program  clients.  Whereas 
one CRCSDP site developed a new data system, others 
augmented  existing  systems  (e.g.,  the  NBCCEDP  data 
system) to integrate the data elements. With support from 
MABs  and  provider  sites,  each  program  also  developed 
data collection forms (e.g., patient enrollment, health his-
tory, FOBT screening). Although staff suggested that the 
development of data systems and forms was not particu-
larly difficult, they observed that it was an especially time-
consuming component of the start-up period.
Treatment resources
Staff  identified  challenges  in  securing  resources  for 
cancer treatment. Because CDC funds cannot be used for 
treatment (17), programs depended on soliciting in-kind 
support or charity care from a provider system viewed by 
staff as already overburdened.
Discussion
The program models and start-up process of the CRCSDP 
offer valuable insight to those with an interest in develop-
ing  colorectal  cancer  screening  programs.  Several  key 
factors emerged from the evaluation of the start-up expe-
rience of the five sites studied here. These factors include 
use of a multidisciplinary team, involvement of an MAB, 
relationships with partners, the use of preexisting resourc-
es,  a  program  model  that  fits  existing  service  delivery 
systems, and adequate planning time.
In these five programs, two to three staff with exper-
tise  in  program  management  and  administration  (e.g., 
collaboration,  contracting,  policy  development),  program 
coordination (e.g., day-to-day management, training, sup-
port), and data management (e.g., data systems, data form 
development)  provided  an  adequate  team  for  program 
start-up. Clinical expertise and comfort discussing clini-
cal issues with MAB members and service providers were 
important skills for the management team.
Access  to  clinicians  with  expertise  in  colorectal  can-
cer was essential to start-up. A well-rounded MAB that 
included professionals in disciplines related to the screen-
ing process (e.g., endoscopists, pathologists, radiologists, 
surgical  oncologists,  social  workers,  community-based 
practitioners) was beneficial.
CDC  and  other  organizations  recognize  that  public 
health problems demand collaborative efforts rather than 
“going it alone” (18,19). Active and extensive partnerships 
were fundamental in helping the programs plan to recruit 
clients,  increase  public  awareness  about  the  need  for 
screening, and facilitate relationships with MAB members 
and screening sites.
The five CRCSDP sites leveraged existing resources to 
build a new colorectal cancer screening program. Partner 
agencies (e.g., CCC, ACS), other screening programs (e.g., 
NBCCEDP), and internal agency departments (e.g., health 
communications,  epidemiology)  helped  reduce  costs  and 
support program development. The length of time needed 
to develop data systems and data collection forms suggests 
new programs may benefit from using existing data forms 
and data collection sets.
These five programs used program models that would 
most easily integrate into existing service delivery systems. 
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for varied implementation approaches within multiple ser-
vice delivery sites for the same program (e.g., five different 
clinical sites providing colonoscopy screening). Reliance on 
in-reach to NBCCEDP clients and overall concerns about 
effectively recruiting men suggest programs may need to 
consider program models that include unique recruitment 
efforts for men.
Although  CDC  had  anticipated  a  6-month  start-up 
period, these programs needed 9 to 11 months to hire staff, 
convene  an  MAB,  develop  policies,  build  partnerships, 
organize a service delivery system, plan for client recruit-
ment, secure treatment resources, and develop data man-
agement systems. One staff member advised, “The devils 
are in the details — all the little things that you have to 
think through that we didn’t even think of — things we 
thought we knew but we didn’t.”
The CRCSDP evaluation team will continue to work with 
the five sites as they provide colorectal cancer screening to 
low-income,  underserved  communities.  The  case  study, 
in particular, contributes to important process evaluation 
efforts that improve our understanding of the CRCSDP’s 
program operations, implementation, and service delivery 
(20). Recognizing that the potential for evaluation to effect 
change is dependent on its use (21), evaluators encourage 
others with an interest in colorectal cancer screening to 
consider the results presented here.
Acknowledgments
We thank participating CRCSDP staff and stakeholders 
and CDC program consultants for their generous contribu-
tion of time and cooperation in the case study evaluation. 
We also thank CDC’s CRCSDP Project Team for ongoing 
support and their review of the manuscript.
Author Information
Corresponding  Author:  Amy  DeGroff,  MPH,  Division 
of  Cancer  Prevention  and  Control,  National  Center  for 
Chronic  Disease  Prevention  and  Health  Promotion, 
Centers for Disease Control and Prevention, 4770 Buford 
Hwy NE, MS K-57, Atlanta, GA 30341. Telephone: 770-
488-2415. E-mail: asd1@cdc.gov.
Author Affiliations: Debra Holden, Sonya Goode Green, 
Research  Triangle  Institute,  Research  Triangle  Park, 
North  Carolina;  Jennifer  Boehm,  Laura  Seeff,  Florence 
Tangka,  Division  of  Cancer  Prevention  and  Control, 
National  Center  for  Chronic  Disease  Prevention  and 
Health  Promotion,  Centers  for  Disease  Control  and 
Prevention, Atlanta, Georgia.
References
 1.  U.S. Cancer Statistics Working Group. United States 
cancer statistics: 2003 incidence and mortality. Atlanta 
(GA): U.S. Department of Health and Human Services, 
National Cancer Institute, Centers for Disease Control 
and Prevention; 2007.
 2.  Mandel JS, Church TR, Bond JH, Ederer F, Geisser 
MS, Mongin SJ, et al. The effect of fecal occult-blood 
screening on the incidence of colorectal cancer. N Engl 
J Med 2000;343(22):1603-7.
 3.  Framework for program evaluation in public health. 
MMWR Recomm Rep 1999;48(RR-11):1-40.
 4.  Stufflebeam  DL.  Evaluation  models.  New  Dir  Eval 
2001;(89):1-106.
 5.  Patton MQ. Qualitative research & evaluation meth-
ods. 3rd ed. Thousand Oaks (CA): SAGE Publications; 
2002.
 6.  Stake RE. The art of case study research. Thousand 
Oaks (CA): SAGE Publications; 1995.
 7.  Stake  RE.  Multiple  case  study  analysis.  New  York 
(NY): Guilford Press; 2006.
 8.  Bogdan  RC,  Biklen  SK.  Qualitative  research  for 
education: an introduction to theories and methods. 
Boston (MA): Allyn and Bacon; 2007.
 9.  Glaser  BG,  Strauss  AL.  The  discovery  of  grounded 
theory:  strategies  for  qualitative  research.  Chicago 
(IL): Aldine; 1967.
10. Krippendorf K. Content analysis: an introduction to its 
methodology. Beverly Hills (CA): SAGE Publications; 
1980.
11. Miles MB, Huberman AM. Qualitative data analysis: 
an expanded sourcebook. Thousand Oaks (CA): SAGE 
Publications; 1994.
12. Creswell JW, Miller DL. Determining validity in quali-
tative inquiry. Theory into Practice 2000;39(3):124-30.
13. Lincoln YS, Guba EG. Naturalistic inquiry. Newbury 
Park (CA): SAGE Publications; 1985.
14. Mathison S. Why triangulate? Educational Researcher 
1988;17(2):13-7.
VOLUME 5: NO. 2
APRIL 2008
  www.cdc.gov/pcd/issues/2008/apr/07_0204.htm • Centers for Disease Control and Prevention  7
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, 
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only 
and does not imply endorsement by any of the groups named above.VOLUME 5: NO. 2
APRIL 2008
15. Merriam  SB.  Qualitative  research  and  case  study 
applications in education. San Francisco (CA): Jossey-
Bass; 1998.
16. WISEWOMAN  —  Well–Integrated  Screening  and 
Evaluation  for  Women  Across  the  Nation.  Atlanta 
(GA):  Centers  for  Disease  Control  and  Prevention. 
http://www.cdc.gov/wisewoman.  Accessed  September 
10, 2007.
17. Colorectal Cancer Screening Demonstration Program. 
Fed Regist 2005;70(99):29747-59.
18. CDC  health  protection  goals  fact  sheet:  goals  for 
the 21st century. Atlanta (GA): Centers for Disease 
Control  and  Prevention.  http://www.cdc.gov/about/
goals/factSheet.htm. Accessed September 10, 2007.
19. Institute  of  Medicine.  The  future  of  the  public’s 
health in the 21st century. Washington (DC): National 
Academies Press; 2003.
20. Rossi  PH,  Freeman  HE,  Lipsey  MW.  Evaluation:  a 
systematic  approach.  6th  ed.  Thousand  Oaks  (CA): 
SAGE Publications; 1999.
21. Weiss CH. Evaluation. 2nd ed. Upper Saddle River 
(NJ): Prentice Hall; 1998.
8  Centers for Disease Control and Prevention • www.cdc.gov/pcd/issues/2008/apr/07_0204.htm
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, 
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only 
and does not imply endorsement by any of the groups named above.
Tables
Table 1. Program Goals and Examples of Evaluation Questions Related to Program Start-Up, Colorectal Cancer Screening 
Demonstration Program, 2006
Goal Evaluation Questions Related to Program Start-Up
Provide sound program planning and management. What staffing is used during program start-up? How are medical advisory boards com-
prised? What is their role during program start-up?
Develop and maintain effective partnerships to ensure sus-
tainability.
What partnerships have been developed to support the program?
Effectively recruit low-income, medically underserved par-
ticipants for colorectal screening through public education 
and outreach.
What priority populations are proposed to be reached? What types of recruitment strategies 
are planned?
Increase the rate of colorectal cancer screening among 
low-income, medically underserved populations.
Not applicable in this phase.
Provide program recipients with appropriate screening and 
rescreening services.
What is the start-up time for programs? How is the provider system structured for services 
delivery?
Assure program recipients receive appropriate diagnosis 
and treatment services.
How will patient navigation services be provided? How have programs secured treatment 
services for clients diagnosed with cancer?
Conduct monitoring, tracking, and evaluation activities. What types of data systems have been developed by programs?
Provide cost-effective services. What in-kind contributions have been secured by programs?
Table 2. Characteristics of Program Models, Colorectal Cancer Screening Demonstration Program, 2006
CRCSDP Program Service Area Test Type Service Delivery Model Provider Network
Maryland Baltimore City Colonoscopy Decentralized 5 hospitals
Missouri St. Louis Fecal occult blood test (FOBT) Centralized  specialty care center and  
medical center
Nebraska Statewide FOBT Centralized State health department
New York Suffolk County Colonoscopy Centralized  university medical center
Washington King, Clallam, and Jefferson 
counties
FOBT Decentralized 0 community health centersTable 3. Composition and Start-Up Activities of Medical Advisory Boards, Colorectal Cancer Screening Demonstration 
Program (CRCSDP), 2006
Disciplines Represented by MABs MAB Start-Up Activities
Gastroenterologists 
Pathologists 
Surgical oncologists 
Surgeons 
Other physicians 
Radiologists 
Physician assistants 
Nurse practitioners 
Social workers 
Partner representatives (ACS, CCC) 
Health department representatives 
Provider site representatives
•  Reviewed CDC policies for the CRCSDP
•  Developed program-specific policies
•  Determined eligibility criteria
•  Advised on screening test, procedures, and bowel preparation materials
•  Advised on patient flow process and quality assurance
•  Reviewed patient-level data variables and data collection forms developed for the program
•  Developed plans to treat patients experiencing medical complications from screening or diagnostic procedures
•  Provided guidance for professional education
•  Reviewed patient education materials
•  Advocated for provider participation and facilitated relationships with medical institutions
•  Advised on treatment issues and advocated for treatment resources
•  Promoted the program in the colorectal cancer and larger cancer community
 
MAB indicates medical advisory board; CDC, Centers for Disease Control and Prevention; ACS, American Cancer Society; CCC, Comprehensive Cancer 
Control.
Table 4. Public Education, Outreach, and In-Reach Strategies by Site, Colorectal Cancer Screening Demonstration Program 
(CRCSDP), 2006
CRCSDP Site Public Education Outreach In-Reach
Maryland ACS No Excuses campaign ACS call-in center with referral to provider 
sites.
Provider site in-reach through other existing 
screening programs (e.g., prostate, breast, 
cervical); referral from federally qualified 
health centers affiliated with provider sites.
Missouri CDC Screen for Life campaign used via 
television and radio advertisements
Outreach through a faith-based organiza-
tion, bus signs, posters in laundromats and 
grocery stores, peer health worker program.
NBCCEDP providers refer potential clients to 
provider site; mailings to NBCCEDP clients 
and their partners.
Nebraska Public education materials adopted from 
Screen for Life, ACS, and NIH’s Cancer 
Information Services
Extensive focus group testing conducted to 
shape messaging; plans for more targeted 
outreach through events (e.g., farm auc-
tions).
NBCCEDP providers refer potential clients to 
state health department.
New York Screen for Life posters, fact sheets, and 
brochures placed in community health 
centers
Video developed to use in community 
health clinic waiting rooms.
0 Suffolk County community health clin-
ics assess initial eligibility and refer to the 
provider site.
Washington ACS materials, CRCSDP brochure devel-
oped in English, Spanish, and Vietnamese
No activities planned. Provider site (primary care clinics) in-reach 
to NBCCEDP clients and other eligible cli-
ents; incentive gift cards for clients.
 
ACS indicates American Cancer Society; CDC, Centers for Disease Control and Prevention; NBCCEDP, National Breast and Cervical Cancer Early Detection 
Program; NIH, National Institutes of Health.
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